Skip to content

Prospective Evaluation of Needle Exsufflation for Pneumothorax

Impact of Pneumothorax Duration Before Treatment on the Success of Needle Exsufflation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02528734
Enrollment
71
Registered
2015-08-19
Start date
2012-01-31
Completion date
2016-11-30
Last updated
2017-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumothorax

Keywords

pneumothorax

Brief summary

Monocentric observational study of needle exsufflation for pneumothorax in the ICU.

Detailed description

The main objective of this prospective observational non interventional study is to investigate a possible relationship between prior duration of pneumothorax (defined as the duration from first occurence of chest pain reported by patient to exsufflation) and the success of exsufflation procedure (defined by the absence of a chest tube insertion in the following 24h).

Interventions

None listed

Sponsors

Hôpital Louis Mourier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult ICU patients requiring needle exsufflation for spontaneous pneumothorax

Exclusion criteria

* refuse to participate * contraindications to needle exsufflation (acute respiratory failure requiring immediate chest tube insertion)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with early success of needle exsufflation24 hrssuccess of needle exsufflation is defined as the absence of chest tube insertion requirement within 24hrs following needle exsufflation
Number of patients with early success of needle exsufflation with duration of symptoms prior to exsufflation greater than 48 hrs24 hrssuccess of needle exsufflation is defined as the absence of chest tube insertion requirement within 24hrs following needle exsufflation; duration of symptoms prior to exsufflation is the time (in hrs) elapsed between first chest pain reported by the patient and needle exsufflation

Secondary

MeasureTime frameDescription
Length of hospital stay15 daysparticipants will be followed for the duration of hospital stay, from hospital admission to hospital discharge, an expected average of 15 days
Length of ICU stay8 daysparticipants will be followed for the duration of ICU stay, from ICU admission to ICU discharge, an expected average of 8 days
Number of patients requiring early surgical pleurodesis because of persistent pneumothorax8 daysPatients will be monitored for eventual need for surgical pleurodesis during their ICU stay because of persistent or worsening pneumothorax
Number of patients with late exsufflation failure8 dayslate exsufflation failure is defined as patients requiring chest tube insertion at least 24 hrs after needle exsufflation because of persistent or worsening of pneumothorax despite initial early success

Other

MeasureTime frameDescription
Maximal patient self-reported pain during procedure30 mintutespatients are asked to assess the maximal pain felt during needle exsufflation or chest tube insertion with the use of a numeric scale from 0 \[no pain\] to 10 \[worst possible pain\]
Number of patients with pneumothorax recurrence30 daysPatients will be followed for an expected average of 30 days to identify those with recurrent pneumothorax
Number of patients with treatment-related adverse event8 daysPatients will be followed for 8 days to identify those with either hemothorax (defined as hematic pleural effusion requiring thoracic drainage); or a vacuo pulmonary edema (defined as occurrence of localised alveolar interstitial opacities on post-procedure chest X-ray); or site of chest tube insertion infection (presence of purulent secretions issuing from chest tube insertion site)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026